|
|
|
Insider
Information: |
Aryeh Jason |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
401,047 |
|
Indirect Shares
|
890,847 |
|
|
Direct
Value |
$7,148,144 |
|
|
Indirect Value
|
$4,945,268 |
|
|
Total
Shares |
1,291,894 |
|
|
Total
Value |
$12,093,412 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-02-23 |
4 |
B |
$9.94 |
$49,700 |
I/I |
5,000 |
267,111 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-11-18 |
4 |
S |
$105.00 |
$525,000 |
I/I |
(5,000) |
204,377 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-03-07 |
4 |
S |
$101.07 |
$568,895 |
I/I |
(5,629) |
236,207 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-05-18 |
4 |
S |
$86.74 |
$520,440 |
I/I |
(6,000) |
249,716 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-11-09 |
4 |
S |
$5.26 |
$33,677 |
I/I |
(6,400) |
217,483 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,517 |
28,318 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-18 |
4 |
S |
$5.96 |
$39,225 |
I/I |
(6,581) |
352,620 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-12-01 |
4 |
S |
$5.53 |
$37,051 |
I/I |
(6,700) |
186,488 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-02-13 |
4 |
S |
$77.43 |
$518,779 |
I/I |
(6,700) |
254,216 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-02-28 |
4 |
S |
$107.58 |
$753,060 |
I/I |
(7,000) |
153,898 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-10-01 |
4 |
OE |
$32.30 |
$236,920 |
D/D |
7,335 |
60,695 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
21,801 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-25 |
4 |
B |
$1.43 |
$10,750 |
D/D |
7,500 |
55,595 |
2.39 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
15,000 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-19 |
4 |
S |
$5.99 |
$46,722 |
I/I |
(7,800) |
345,420 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2009-12-22 |
4 |
S |
$5.24 |
$42,103 |
I/I |
(8,035) |
779,385 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-10-20 |
4 |
S |
$5.01 |
$42,851 |
I/I |
(8,553) |
223,883 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-01-31 |
4 |
OE |
$5.00 |
$47,500 |
I/I |
9,500 |
495,536 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-02-14 |
4 |
S |
$78.87 |
$749,265 |
I/I |
(9,500) |
244,716 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-14 |
4 |
B |
$2.64 |
$25,608 |
I/I |
9,700 |
81,266 |
2.1 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-30 |
4 |
B |
$2.61 |
$25,790 |
I/I |
9,900 |
9,900 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-05-05 |
4 |
S |
$120.21 |
$1,202,121 |
I/I |
(10,000) |
225,707 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-05-31 |
4 |
B |
$2.35 |
$23,771 |
I/I |
10,133 |
536,104 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-10-09 |
4 |
B |
$42.99 |
$472,890 |
I/I |
11,000 |
255,716 |
2.1 |
- |
|
175 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|